Sunshine Biopharma (SBFM) Other Gross PP&E Adjustments (2019 - 2025)
Sunshine Biopharma (SBFM) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with $240067.0 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Other Gross PP&E Adjustments rose 144.34% year-over-year to $240067.0, compared with a TTM value of $240067.0 through Sep 2025, up 144.34%, and an annual FY2024 reading of -$53449.0, up 41.21% over the prior year.
- Other Gross PP&E Adjustments was $240067.0 for Q3 2025 at Sunshine Biopharma, up from $158163.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $240067.0 in Q3 2025 and bottomed at -$728129.0 in Q1 2023.
- Average Other Gross PP&E Adjustments over 4 years is -$320794.2, with a median of -$411911.0 recorded in 2022.
- The sharpest move saw Other Gross PP&E Adjustments rose 17.56% in 2024, then soared 144.34% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$282354.0 in 2022, then surged by 67.8% to -$90915.0 in 2023, then skyrocketed by 41.21% to -$53449.0 in 2024, then soared by 549.15% to $240067.0 in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for SBFM at $240067.0 in Q3 2025, $158163.0 in Q2 2025, and -$11923.0 in Q1 2025.